Split History
ETFs Holding PDLI »    PDLI Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
PDL BioPharma is engaged in acquiring commercial stage pharmaceutical assets as well as late clinical stage pharmaceutical products. Co. operates in three segments: Pharmaceutical, which consists of prescription medicine products sold under the name Tekturna®, Tekturna HCT®, Rasilez®, and Rasilez HCT®; Medical Devices, which consists of the LENSAR® Laser System; and Income Generating Assets, which consists of notes and other long-term receivables, royalty rights and hybrid notes/royalty receivables, equity investments and royalties from issued patents in the United States and elsewhere, covering the humanization of antibodies, which it refers to as the Queen et al. patents. According to our PDLI split history records, PDL BioPharma has had 2 splits.
PDLI split history picture
PDL BioPharma (PDLI) has 2 splits in our PDLI split history database. The first split for PDLI took place on August 23, 2000. This was a 2 for 1 split, meaning for each share of PDLI owned pre-split, the shareholder now owned 2 shares. For example, a 1000 share position pre-split, became a 2000 share position following the split. PDLI's second split took place on October 10, 2001. This was a 2 for 1 split, meaning for each share of PDLI owned pre-split, the shareholder now owned 2 shares. For example, a 2000 share position pre-split, became a 4000 share position following the split.

When a company such as PDL BioPharma splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business. Looking at the PDLI split history from start to finish, an original position size of 1000 shares would have turned into 4000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into PDL BioPharma shares, starting with a $10,000 purchase of PDLI, presented on a split-history-adjusted basis factoring in the complete PDLI split history. PDLI split adjusted history picture

Growth of $10,000.00
With Dividends Reinvested

Start date: 11/23/2009
End date: 11/21/2019
Start price/share: $7.86
End price/share: $3.12
Starting shares: 1,272.26
Ending shares: 3,219.46
Dividends reinvested/share: $6.27
Total return: 0.45%
Average Annual Total Return: 0.04%
Starting investment: $10,000.00
Ending investment: $10,040.07
Years: 10.00
 
Growth of $10,000.00
Without Dividends Reinvested

Start date: 11/23/2009
End date: 11/21/2019
Start price/share: $7.86
End price/share: $3.12
Dividends collected/share: $6.27
Total return: 19.47%
Average Annual Total Return: 1.79%
Starting investment: $10,000.00
Ending investment: $11,941.29
Years: 10.00
Date Ratio
08/23/20002 for 1
10/10/20012 for 1
PDLI is categorized under the Financials sector; below are some other companies in the same sector that also have a history of stock splits:

PDM Split History
PEB Split History
PEBK Split History
PEBO Split History
PEI Split History
PEO Split History
PFBC Split History
PFBI Split History
PFBX Split History
PFI Split History

Also explore: PDLI shares outstanding history

NeuroMetrix, Inc. (NURO)
TRACON Pharmaceuticals (TCON)
SELLAS Life Sciences Group, Inc. (SLS)
Tonix Pharmaceuticals Holding Corp. (TNXP)
Camber Energy, Inc. (CEI)
Cancer Genetics, Inc. (CGIX)
Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 3X Shares (GUSH)
Kingold Jewelry, Inc. (KGJI)
Aethlon Medical, Inc. (AEMD)
Aberdeen Standard Physical Gold Shares ETF (SGOL)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

PDLI Insider Buying

PDLI Split History | www.SplitHistory.com | Copyright © 2013 - 2019, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.